Untethering the Cord: How can HSD Support Tethered Cord Syndrome
Tethered cord syndrome (TCS) is often framed as a surgical problem—a mechanical tethering of the spinal cord that causes pain, bladder dysfunction, and neurological decline. But what if the “tether” isn’t just anatomical? What if it’s functional, fluid-based, and fascia-driven?
Recent insights from the Fascia-Centered Detoxification HSD Case Report by (Jennifer Brandolino RN, CiHom, 2024) suggest that fascia adhesions and lymphatic stagnation may mimic or exacerbate tethered cord symptoms. And that’s where Homeopathic Spike Detox, also known as HSD enters the conversation—not as a cure, but as a systems-based adjunct that may help restore fascia integrity and fluid dynamics.
Fascia Dysfunction: The Hidden Tether
The HSD case report documents a 62-year-old woman with connective tissue symptoms, neuropathy, and sacral pain—hallmarks of TCS. Imaging was inconclusive, but clinical signs pointed to spinal cord traction. Instead of surgery, she underwent the HSD protocol, which combines:
• Homeopathic detoxification targeting spike protein residues
• Fascia mobilization and lymphatic stimulation
• Nutritional and energetic support for connective tissue resilience
The results? Marked improvement in bladder function, pain reduction, and neurological clarity. The fascia itself—once dense and adhesive—became more pliable, suggesting that the “tether” was functional, not fixed.
HSD’s Mechanism: Fascia, Fluid, and Mast Cells
Why might HSD help in cases like this?
• Mast cell modulation: Mast cells are abundant in fascia and contribute to neuroinflammation. HSD’s detox profile may help stabilize mast cell activity, reducing pain and hypersensitivity.
• Lymphatic and CSF drainage: Improved fluid movement may relieve pressure on the spinal cord and reduce traction-like symptoms.
• Fascia elasticity: By supporting collagen integrity and reducing inflammatory load, HSD may help restore fascia’s natural glide and resilience.
This aligns with emerging research on hypermobile Ehlers-Danlos syndrome (hEDS), where connective tissue laxity and mast cell activation often co-occur with TCS and cranio cervical instability.
Supporting Research and Case Studies
• NIH Symposium (Jan 2024): “Lesser Studied Pathologies” highlighted the diagnostic complexity of TCS in hEDS patients, emphasizing the role of fascia and fluid dynamics in symptom presentation.
• Frontiers in Neurology: A peer-reviewed study documented the co-occurrence of tethered cord syndrome and craniocervical instability in hEDS, suggesting a shared pathophysiological basis involving connective tissue laxity and spinal traction.
• Remnant Healthcare Case Study: Over 90% of participants using HSD reported symptom relief, including improvements in neuropathy, bladder dysfunction, and spinal pain—hallmarks of TCS.
• Fascia-Centered Detoxification Case Report:
Rethinking Tethered Cord: Beyond the Scalpel
The fascia-centered model challenges the binary of “surgical vs. not surgical.” It invites a third path: functional untethering through detoxification, fascia release, and systemic support.
For patients with
hEDS, mast cell activation, and TCS-like symptoms, HSD may offer:
• A low-risk, non-invasive adjunct to traditional care
• A way to address the inflammatory and mechanical contributors to tethering
• A bridge between clinical research and practitioner distribution—especially when imaging is inconclusive
Final Thoughts
Tethered cord syndrome is more than a structural diagnosis—it’s a fascia story, a fluid story, and a systems story. HSD may help rewrite that story by restoring balance where surgery cannot.
As we continue to explore fascia’s role in neurological health, HSD deserves a place in the conversation—not as a replacement for clinical care, but as a fascia-first ally in the untethering journey.
Written by: Jen Dillon
Learn more about the HSD clinical research at: www.getdetoxed.us
Footnotes
¹ Fascia-Centered Detoxification Case Report – Dropbox
² Remnant Healthcare – Homeopathic Spike Detox Protocol
³ Frontiers in Neurology – Co-occurrence of TCS and CCI in hEDS
⁴ NIH Symposium – “Lesser Studied Pathologies” (January 2024)